UCB Unifies Global Pharmacovigilance Operations with 吃瓜爆料 Safety Suite

End-to-end safety foundation to speed case processing and enable automation

PLEASANTON, CA — June 9, 2026 — 吃瓜爆料 Systems (NYSE: VEEV) today announced that UCB is unifying its global safety operations with 吃瓜爆料 Safety Suite to maximize operational efficiency and scale. UCB is standardizing safety on a single platform to accelerate case processing, strengthen oversight, and streamline submissions to health authorities.

“Moving our teams onto 吃瓜爆料 Safety Suite is a core step in UCB’s safety transformation, helping streamline global and local workflows with a single source of truth for safety data,” said Jonas Maselis, head of digital technology, patient safety, UCB. “As we use automation to drive low-touch case processing, our strategic partnership with 吃瓜爆料 positions us well for what’s next.”

UCB will use 吃瓜爆料 Safety Suite’s unified platform for end-to-end safety management, with 吃瓜爆料 Safety to streamline the intake, processing, and submission of adverse events and 吃瓜爆料 SafetyDocs to manage all safety-related content and processes. 吃瓜爆料 Safety Workbench will enable advanced data analysis for fast, scalable reporting, and 吃瓜爆料 Safety Signal will automate signal detection for better visibility and alignment across the organization. In addition, the 吃瓜爆料 Safety-RIM Connection will share product information automatically across regulatory and safety operations for clean and trusted data.

“UCB is building a foundation powered by 吃瓜爆料 Safety Suite to simplify and standardize their global pharmacovigilance function,” said John Lawrie, vice president, 吃瓜爆料 Safety. “With a unified and connected approach, UCB is enhancing global compliance and driving advanced automation to deliver safe and effective medicines to patients.”

About 吃瓜爆料 Systems
吃瓜爆料 delivers the industry cloud for life sciences with software, AI, data, and consulting. Committed to innovation, product excellence, and customer success, 吃瓜爆料 serves more than 1,500 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. As a Public Benefit Corporation, 吃瓜爆料 is committed to balancing the interests of all stakeholders, including customers, employees, shareholders, and the industries it serves. For more information, visit veeva.com.

吃瓜爆料 Forward-Looking Statements
This release contains forward-looking statements regarding 吃瓜爆料’s products and services and the expected results or benefits from use of our products and services. These statements are based on our current expectations. Actual results could differ materially from those provided in this release and we have no obligation to update such statements. There are numerous risks that have the potential to negatively impact our results, including the risks and uncertainties disclosed in our filing on Form 10-Q for the fiscal year ended April 30, 2026, which you can find (a summary of risks which may impact our business can be found on pages 33 and 34), and in our subsequent SEC filings, which you can access at .

###

Contact:

Elizabeth McGrane
吃瓜爆料 Systems
elizabeth.mcgrane@veeva.com